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ABSTRACT 
In this study, the metabolic, enzymatic and gene changes causing cerebral glucose 
dysmetabolism following graded diffuse traumatic brain injury (TBI) were evaluated. TBI 
was induced in rats by dropping 450g from 1 (mild TBI; mTBI) or 2 m height (severe TBI; 
sTBI). After 6, 12, 24, 48, and 120 h gene expressions and enzymatic activities of glycolysis 
and pentose phosphate pathway (PPP) enzymes, and levels of lactate, ATP, ADP, ATP/ADP 
(indexing mitochondrial phosphorylating capacity), NADP+, NADPH and GSH were 
determined in whole brain extracts (n = 6 rats at each time for both TBI levels). Sham-
operated animals (n = 6) were used as controls. Results demonstrated that mTBI caused a late 
increase (48-120 h post injury) of glycolytic gene expression and enzymatic activities, 
concomitantly with mitochondrial functional recovery (ATP and ATP/ADP normalization). 
No changes in lactate and PPP genes and enzymes, were accompanied by transient decrease 
in GSH, NADP+, NADPH and NADPH/NADP+. Animals following sTBI showed early 
increase (6-24 h post injury) of glycolytic gene expression and enzymatic activities, occurring 
during mitochondrial malfunctioning (50% decrease in ATP and ATP/ADP). Higher lactate 
and lower GSH, NADP+, NADPH, NADPH/NADP+ than controls were recorded at anytime 
post injury (p < 0.01). Both TBI levels caused metabolic and gene changes affecting glucose 
metabolism. Following mTBI, increased glucose flux through glycolysis is coupled to 
mitochondrial glucose oxidation. “True” hyperglycolysis occurs only after sTBI, where 
metabolic changes, caused by depressed mitochondrial phosphorylating capacity, act on 
genes causing net glycolytic flux increase uncoupled from mitochondrial glucose oxidation. 
 
Key words: Traumatic brain injury; glucose dysmetabolism; glycolysis; pentose phosphate 
pathway; energy metabolism; mitochondrial dysfunction. 
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1. INTRODUCTION 
 
Physiologically, the brain supports its energy demand by using glucose as its main metabolic 
fuel (1). To ensure maximal energy yield, glucose must be fully oxidized through 
mitochondrial/oxygen dependent reactions (2), since glycolysis contributes to ATP generation 
with a modest 5.26% and mitochondria with 94.74%. Hence, to sustain the cerebral energy 
demand, glucose consumption must be coupled to mitochondrial functions and oxygen 
consumption, i.e. oxidative phosphorylation must generate 3 or 2 ATP/pair of electrons 
transferred from NADH or FADH2 to ½O2 via the electron transfer chain (ETC)
1
. 
Pathologically, cerebral energy state imbalance can occur for two reasons: i) 
hypoxia/ischemia, when decrease in the cerebral blood flow (CBF) decreases oxygen delivery 
to the tissue and mitochondria (3-5); ii) mitochondrial dysfunction, when the stoichiometric 
ratio - moles of transferred electrons through ETC/moles of O2 reduced to water/moles of 
ATP produced by complex V – is impaired (6, 7). The profound distinction between these 
two phenomena is that the latter occurs under adequate CBF and tissue oxygen delivery (8). 
Decrease in mitochondrially generated ATP during cerebral energy dysmetabolism is partly 
counterbalanced by increasing the glycolysis rate (9-11). 
 
1
Abbreviations used in the text are: CBF, cerebral blood flow; ETC, electron transfer chain; 
TBI traumatic brain injury; mTBI, mild traumatic brain injury; sTBI, severe traumatic brain 
injury; PPP, pentose phosphate pathway; PEP, phosphoenolpyruvate; 1,3-BPG, 1,3-
bisphosphoglycerate; G-6-PDH, glucose-6-phosphate dehydrogenase; 6-PGDH, 6-
phosphogluconate dehydrogenase; TIM, triosephosphate isomerase; GDH, glycerol-3-
phosphate dehydrogenase; LDH, lactate dehydrogenase; LOD, lactate oxidase; B2M, -2-
microglobulin; HK, hexokinase; PFK, phosphofructokinase; PGK, phosphoglycerokinase; 
PK, pyruvatekinase. 
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Experimental and clinical evidences demonstrated that traumatic brain injury (TBI), the 
leading cause of death and disability under 45 years of age in Western countries (12), 
provokes cell energy state derangement (13), mitochondrial dysfunction (14, 15) and ATP 
decrease (13, 16). Mitochondrial dysfunction with energy crisis may be transient, as in mild 
TBI (mTBI) (13), or permanent, as in severe TBI (sTBI) (13, 15). Several studies evidenced 
brain energy dysregulation even in TBI patients (10, 17-20). Hyperglycolysis, i.e. the 
increased glucose consumption rate through glycolysis with no parallel increase in 
mitochondrial (oxygen) dependent glucose oxidation, and stimulation of the pentose 
phosphate pathway (PPP) were reported as common features following TBI (21-24). Both 
phenomena occur early post injury and are protracted for a not well-defined period after TBI 
(21, 25). Currently, no information about the timing of glucose dysmetabolism, influence of 
injury severity and changes in the gene expression and activity of the glycolytic and PPP 
enzymes are available.  
Here, we investigated the gene expressions and activities of glycolytic and PPP enzymes, as 
well as the levels of lactate, ATP, ADP, ATP/ADP ratio, NADP
+
, NADPH and GSH, at 
different times following graded diffuse TBI in rats, highlighting a multifactorial metabolic, 
enzymatic and gene contributions affecting glucose and energy metabolism in the post-
injured brain.  
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2. MATERIALS AND METHODS 
 
2.1 Experimental protocol  
The experimental protocol was approved by the Ethical Committee of the Catholic University 
of Rome, in accordance with the United States Public Health Service's Policy on Humane 
Care and Use of Laboratory Animals. Male Wistar rats of 300-350g were randomly divided 
into: 1) sham-operated as control; 2) mild diffuse TBI (mTBI group); 3) severe diffuse TBI 
(sTBI group). As for the anesthetic mixture, animals received 35 mg/kg b.w. ketamine and 
0.25 mg/kg b.w. midazolam by i.p. injection. TBI was induced by dropping a 450 g weight 
from 1m (mTBI) or 2m height (sTBI), according to the weight drop impact acceleration 
model (26). Rats that suffered from skull fracture, seizures, nasal bleeding, or did not survive 
the impacts (n = 6 in the sTBI group), were discarded and not included in the study. At 6, 12, 
24, 48, and 120 h from injury, rats (n = 9 for each time point in both groups of injured 
animals) were again anesthetized and then immediately sacrificed. Sham-operated animals 
sacrificed 120 h after the initial anesthesia (n = 9) were used as controls.  
 
2.2 Tissue preparation for the determination of gene expressions, enzymatic activities and 
metabolites 
As described in detail elsewhere (27), an in vivo craniectomy was performed in all animals 
during anesthesia and the two hemispheres were freeze-clamped in liquid nitrogen to 
minimize metabolite loss (28, 29). Total RNA was extracted by homogenizing one 
hemisphere in Trizol (Invitrogen Life Technologies), using the Ultra-Turrax homogenizer 
(Janke Kunkel, Staufen, Ge) at 24,000 rpm/min, to produce a final 10% homogenate 
(weight:volume). Crude homogenates suitable to measure enzymatic activities, were obtained 
by homogenizing one hemisphere in 15 mM KCl + 1 mM KH2PO4, pH 7.4, at 24,000 
rpm/min for 90 sec in the cold, followed by centrifugation at 18,690 x g for 15 min at 4 °C. 
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The tissue preparation for the simultaneous HPLC analysis of ATP, ADP, GSH, NADP
+
 and 
NADPH was performed on one hemisphere, using the organic solvent deproteinization 
described elsewhere (30). As previously indicated (29, 31), the utilization of these protocols 
for tissue manipulation and the proper mixing of the different processing of the right and left 
hemispheres, allowed the simultaneous determination of the gene expressions (three right + 
three left hemispheres), enzyme activities (three right + three left hemispheres) and 
quantification of metabolites (three right + three left hemispheres), by using nine animals for 
each time point. 
 
2.3 Analysis of gene expressions of the main glycolytic and PPP enzymes 
Transcription to cDNA of RNA extracted from brain samples and subsequent real time-
quantitative polymerase chain reaction (RT-qPCR) were performed as previously described 
(29, 31). Primers, reported in Table 1, were designed with the 0.2 version of the Primer3 
Input software developed by the Whitehead Institute for Biomedical Research (Cambridge, 
MA) and using as templates the sequences of Rattus norvegicus published by the National 
Center for Biotechnology Information. For accurate gene expression measurements with 
RTqPCR, results were normalized to the housekeeping genes of beta-2-microglobulin (B2M, 
NM_012512) and Ubiquitin C (Ubc NM_017314.1) of Rattus norvegicus, selected from 
twelve candidate reference genes using the geNorm Housekeeping Gene Selection Kit 
(Primer Design Ltd.). Changes in transcript abundance of tested genes were calculated using 
the 2
−ΔΔCT
 method described by Livak and Schmittgen (32). 
 
2.4 Determination of the activities of selected glycolytic and PPP enzymes 
The activities of the glycolytic enzymes hexokinase (HK), phosphofructokinase (PFK), 
phosphoglycerokinase (PGK), pyruvatekinase (PK) and lactate dehydrogenase (LDH), and of 
the PPP enzymes glucose-6-phosphate dehydrogenase (G-6-PDH) and 6-phosphogluconate 
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dehydrogenase (6-PGDH) were determined on 100 l of 10% homogenates, prepared as 
above described. In the case of HK, PFK PK, LDH, G-6-PDH and 6-PGDH the reactions 
were carried out at 37 °C according to standardized protocols (33). The change in absorbance 
of NAD(P)
+
 or NADH was followed spectrophotometrically at 340 nm wavelength, using an 
Agilent 89090A spectrophotometer (Agilent Technologies, Santa Clara Ca, USA). In the case 
of PGK, the amount of the reaction product was measured by HPLC. Briefly, a reaction 
mixture containing (in final concentrations) 20 mM Tris-HCl, pH 7.8, 10 mM MgCl2, 1.5 mM 
1,3-BPG, 4 mM ADP and 100 l sample was incubated at 37 °C. Before and after 5, 10 and 
20 minutes of 1,3-BPG supplementation, aliquots of the mixture were withdrawn, 
deproteinized (30) and then loaded onto the HPLC column to measure the amount of ATP 
produced. In brain extracts processed for the enzymatic analysis, proteins were measured 
according to the Bradford method (34). Enzyme activities were expressed as mU/mg protein. 
In the case of HK, PFK, PK, LDH, G-6-PDH and 6-PGDH calculations were performed using 
6.3 x 10
-3
, as the millimolar extinction coefficient of NADP
+
 or NAD(P)H at 340 nm 
wavelength. 
 
2.5 Analyses of metabolites 
The spectrophotometric lactate determination was carried out on 50 l of brain tissue extracts 
following the lactate oxidase method described by Artiss et al. (35). The simultaneous 
separation and quantification of ATP, ADP, NADP
+
, NADPH and GSH in deproteinized 
brain extracts (20 l), or ATP quantification in deproteinized PGK reaction mixtures (200 l), 
was performed by high performance liquid chromatography (HPLC), according to methods 
formerly set up in our laboratory (30, 36, 37). 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
 
8 
2.6 Statistical analysis 
Normal data distribution was tested using the Kolmogorov-Smirnov test. The within-group 
comparison at each time was performed by the one-way analysis of variance (ANOVA). 
Differences across groups were estimated by the two-way ANOVA for repeated measures. 
Fisher’s protected least square was used as the post hoc test. Only two-tailed p-values of less 
than 0.05 were considered statistically significant. 
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3. RESULTS 
 
A mortality rate of 11.8% (6/51 rats) was recorded in the group of sTBI, whilst all mTBI rats 
survived to the impact for the desired time. This grossly accounts for the different severity of 
injury using this model of TBI. 
 
3.1 Effect of graded TBI on the gene expression and enzymatic activity of HK 
During 24 h post injury, mTBI rats showed no changes in the HK1gene expression (Fig. 1A). 
At 48 and 120 h post impact, the HK1 gene expression increased by 2.3 and 3.5 fold (p < 
0.001 respect to controls). Conversely, sTBI rats showed a very rapid 1.8 and 3.2 fold 
increase at 6 and 24 h post injury (p < 0.01 respect to both controls and corresponding times 
of mTBI). A tendency to normalization at 48 and 120 h after injury, when HK1 
overexpression in sTBI rats was significantly lower than values determined in mTBI animals 
(p < 0.01), was then recorded. The HK enzymatic activity in mTBI rats (Fig. 1B) increased by 
1.4 and 2 fold only at 48 and 120 h post trauma (p < 0.01 compared to controls). In sTBI rats 
HK activity (Fig. 1B) showed a significant 1.9 and 2 fold increase at 24 and 48 h (p < 0.01 
compared to both controls and mTBI animals). However, at 120 h after injury HK values 
were similar to those of controls, but significantly lower than those found in mTBI rats (p < 
0.01). 
 
3.2 Effect of graded TBI on the gene expression and enzymatic activity of PFK 
Similarly to HK1, the gene expression of PFKL (Fig. 1C) did not change shortly (6 and 24 h) 
after an mTBI. Prolonging the time of recovery to 48 and 120 h produced a striking 3.8 and 
6.2 times overexpression of the PFKL gene (p < 0.01 respect to controls) (Fig. 1C). 
Differently, the PFKL gene expression in sTBI animals showed a bell-shaped curve with a 
progressive increase over the control value by 2.3 and 5.7 times at 6 and 24 h post injury (p < 
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0.01 respect to both controls and mTBI rats). At 48 and 120 h post sTBI, the PFKL 
expression tended to normalize and at 120 h it was 2.5 lower than the value measured in 
mTBI animals (p < 0.01). The PFK enzymatic activity almost mirrored the changes in the 
gene expression of PFKL (Fig. 1D). Therefore, mTBI produced a significant increase in PFK 
activity at 48 and 120 h (p < 0.01 compared to controls). Severely injured animals had a 
maximum of PFK activity at 24 h post impact (p < 0.01 compared to both controls and mTBI 
rats), hereinafter showing a slow tendency to normalization. Again, after 120 h sTBI animals 
had PFK activity lower (1.5 times) than that measured in mTBI rats (p < 0.01).  
 
3.3 Effect of graded TBI on the gene expression and enzymatic activity of PGK 
The gene expression of PGK1 in mTBI injured rats (Fig. 2,A) progressively increased by 2.4, 
4.1 and 5.2 times at 24, 48 or 120 h from impact (p < 0.001 respect to controls). In sTBI rats, 
the PGK1 gene was overexpressed at any time after injury (p < 0.001 compared to controls), 
with a trend to normalize at 48-120 h post injury (Fig. 2A). Again, sTBI rats exhibited, at 120 
h post trauma, a 2.5 fold lower expression of PGK than mTBI animals (p < 0.01). The 
enzymatic activity of PGK (Fig. 2B) was significantly higher than that of controls at 48 
(+152%, p < 0.01) and 120 h (+262%, p < 0.01), in rats receiving an mTBI; conversely, in 
sTBI rats (Fig. 2B) PGK progressively increased during the initial 24 h followed by a return 
towards pre-impact values hereinafter. At 120 h after sTBI, PGK activity was equal to that of 
controls but lower that that of mTBI rats (p < 0.01).  
 
3.4 Effect of graded TBI on the gene expression and enzymatic activity of PK 
The gene expression of PKM in mTBI rats (Fig. 2C) was significantly overexpressed only at 
48 and 120 h from impact (1.8 and 2.2 times higher than controls p < 0.01). In sTBI rats, the 
PKM gene was overexpressed at 6 and 24 h post injury (1.7 and 2.1 times higher than the 
value of controls, p < 0.01) with no differences from controls at 48 and 120 h post impact 
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(Fig. 2C). At this time point, PKM expression in sTBI rats was almost 3 orders of magnitude 
lower than that of mTBI animals (p < 0.01). The enzymatic activity of PK (Fig. 2D) was 
significantly higher than that of controls only at 48 and 120 h post mTBI (p < 0.01). In sTBI 
rats (Fig. 2D) PK activity was higher than both controls and mTBI injured animals only at 24 
h after trauma (p < 0.01). At 120 h after injury PK activity of sTBI animals was equal to that 
of controls but almost 3 times lower that that of mTBI rats (p < 0.01). 
 
3.5 Effect of graded TBI on the gene expression and enzymatic activity of LDH 
Figures 3A and 3B illustrate the changes in the expressions of the genes controlling the 
synthesis of the two subunits of the tetrameric enzyme LDH, i.e. LDHA and LDHB. The 
expression of both genes was evaluated since neurons and astrocytes contain, in different 
proportions, the two omotetrameric LDH isoforms composed by four identical A or B type 
subunits. In mTBI animals, no change of LDHA was observed at any time post injury (Fig. 
3A), while significant increase in LDHB expression (p < 0.01 compared to controls) was 
recorded at 120 h after trauma (Fig. 3B). Following sTBI, expressions of both LDHA (Fig. 
3A) and LDHB (Fig. 3B) significantly increased compared to both controls and mTBI rats (p 
< 0.05). In consequences of this differential gene expression, activity of total LDH (Fig. 3C) 
increased only at 120 h in mTBI rats (p < 0,05 respect to both controls and sTBI animals) and 
at 48 h in sTBI rats (p < 0,05 respect to both controls and mTBI animals). 
 
3.6 Effect of graded TBI on the gene expression of additional glycolytic enzymes 
Changes in the gene expression of aldolase (ALDOC), glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and neuronal specific enolase (ENO2) are reported in Table 2. As 
occurred to the other glycolytic enzymes, the post TBI gene expressions of ALDOC, GAPDH 
and ENO2 was influenced by either the severity of injury or the time interval after impact. In 
mTBI rats, the gene expression of the three enzymes significantly increased respect to 
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controls at 48 and 120 h post trauma (p < 0.05), with GAPDH and ENO2 showing the most 
evident changes. When considering these gene expressions in sTBI animals, it can be 
observed that ALDOC was significantly increased at 24 and 48 h post injury and GAPDH at 
24 h only, whilst ENO2 did not show any significant variation during our observational 
period. 
 
3.7 Effect of graded TBI on the enzymatic activity of G-6-PDH 
It is worth recalling that it was not possible to measure the expression of the G6PDH gene 
since the sequence of the Rattus norvegicus, nor of the Mus musculus gene is available. 
Therefore, only the G-6-PDH activity was assessed. In mTBI animals, no significant changes 
in G-6-PDH activity at any time after trauma were observed (Fig. 4A). Conversely, a 2 and 
1.5 fold increase, respectively at 24 and 48 h post impact (p < 0.05 compared to both controls 
and mTBI rats), was recorded in rats receiving an sTBI. 
 
3.8 Effect of graded TBI on the gene expression and enzymatic activity of 6-PGDH 
The expression of 6-PGDH in mTBI rats did not vary at any time point after injury (Fig. 4B), 
whilst severe injury caused 6-PGDH to overexpress slightly only after 24 and 48 h (p < 0.05 
compared to both controls and mTBI rats). Similarly to G-6-PDH, mTBI did not provoke any 
change in the activity of 6-PGDH (Fig. 4C), which modestly increased only after 24 and 48 h 
after sTBI (p < 0.05 compared to both controls and mTBI rats). 
 
3.9 Effect of graded TBI on the gene expression of additional PPP enzymes 
Table 2 indicates that the gene expression of TKT (transketolase) was not affected by either 
mTBI or sTBI. The expression of TALDO1 (transaldolase) did not change in mTBI rats but 
underwent a slight but significant downregulation in animals receiving an sTBI (p < 0.05 
compared to controls).  
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3.10 Effect of graded TBI on brain lactate, energy metabolism and mitochondrial functions 
In Figure 5, the time course changes of lactate, ATP, ADP and ATP/ADP ratio in rats 
following mTBI or sTBI are reported. Rats experiencing an mTBI, did not show significant 
changes in whole brain lactate at any time post injury (Fig. 5A). Conversely, sTBI caused 
brain lactate to increase from 1.83 mol/g wet weight (value of controls) to 4.76 mol/g wet 
weight at 6 h post impact (p < 0.01 compared to both controls and mTBI rats). A slow decline 
in cerebral lactate levels occurred in sTBI rats at 24 (3.76 mol/g wet weight) and 48 h (3.22 
mol/g wet weight). At 120 post impact, lactate levels were still +44% higher than the value 
of controls (2.64 mol/g wet weight, p < 0.01 compared to both controls and mTBI animals). 
The time course of ATP concentrations (Fig. 5B) was characterized by a biphasic trend in 
mTBI animals, with an initial decrease (minimum of ATP recorded at 24 h post injury) 
followed by spontaneous recovery up to complete normalization within 48-120 h. Severely 
injured rats showed a remarkable ATP decrease early after impact (-31% at 6 h, p < 0.01 
respect to both controls and mTBI rats), followed by no recovery even at 120 h post sTBI, 
when ATP was only the 65% of the control value (p < 0.01 compared to both controls and 
mTBI rats). Following an mTBI, no changes in ADP concentration were recorded (Fig. 5C). 
However, cerebral ADP levels increased in sTBI animals, with significantly higher values at 
any time post injury (p < 0.01 compared to controls and mTBI rats at corresponding times). 
When calculating the ATP/ADP ratio (Fig. 5D), which is considered an index of the 
mitochondrial phosphorylating capacity (38), it was observed that this progressively declined 
during the first 24 h post injury in mTBI rats (-35% decrease recorded at 24 h; p < 0.01 
compared to controls) and spontaneously recovered afterwards, up to reach the pre-impact 
values at 120 h after injury. Conversely, the ATP/ADP ratio in sTBI rats sharply declined by 
53% at 6 h from trauma (p < 0.01) and subsequently remained lower by about 60% than the 
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control value (p < 0.01), thus suggesting a permanent impairment of the ETC-coupled 
oxidative phosphorylation, i.e. the main mitochondrial function.  
 
3.11 Effect of graded TBI on GSH homeostasis 
To evaluate whether the TBI-induced changes in the gene expressions and activities of the 
two NADPH-generating enzymes of the PPP (G-6-PDH and 6-PGDH) were connected to 
GSH homeostasis, we measured GSH, NADP
+
 and NADPH, and we calculated the 
NADPH/NADP
+
 ratio, at the different times following graded injury. Data indicate (Fig. 6A) 
that mTBI caused a transient decrease in GSH cerebral content at 24 and 48 h post injury, 
when this antioxidant decreased by 20 and 15% (p < 0.05 compared to controls). Conversely, 
GSH in sTBI was significantly lower than that of controls at any time point (p < 0.01). It is 
worth highlighting that at 120 h a 46% decrease in GSH occurred in sTBI animals (p < 0.01 
compared to both controls and mTBI rats). NADP
+
 (Fig. 6B) NADPH (Fig. 6C) and 
NADPH/NADP
+
 (Fig. 6D) did not change at any time following mTBI. On the contrary, a 
steady decline of these parameters was recorded in sTBI animals with minimal values 
determined at 120 h post impact (p < 0.01 compared to both controls and mTBI rats).  
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4. DISCUSSION 
 
We have here demonstrated that the cerebral glucose dysmetabolism following TBI, causing 
profound changes in energy and redox balance, does not only depend on the alterations of the 
complex regulatory mechanisms of metabolic pathways and cycles (1, 39) but it is also 
influenced by overexpression of genes encoding for glycolytic enzymes and for selected PPP 
enzymes.  
Using a graded diffuse (non focal) TBI model (26), we showed that the expressions of the 
genes encoding for the four kinases of glycolysis, namely HK, PFK, PGK and PK, undergo 
time-dependent and severity-dependent changes, causing differential changes of their 
respective activities. When considering the HK1, PFKL, PGK1 and PK genes, as well as the 
corresponding enzymatic activities (HK, PFK, PGK and PK), the most striking difference 
between mTBI and sTBI was the very different timing in their overexpression or change in 
activity, occurring within 120 h from injury.  
In mildly injured rats, whilst no changes occurred during the first 24 h, a 3 to 5 fold increases 
in the expressions of these genes took place between 48 and 120 h post impact (Fig. 1 and 2), 
with the consequent increase in the corresponding enzyme activities, mainly occurring 120 h 
after trauma (Fig. 1 and 2). This pattern was also observed for the glycolytic ALDOC, 
GAPDH and ENO2 genes (Table 2), thus confirming a differential timing following mTBI or 
sTBI. These results are connected to the variations of whole brain lactate, energy metabolites 
(ATP and ADP) and mitochondrial phosphorylating capacity (ATP/ADP ratio), occurring 
after an mTBI (Fig 5), indicating a transient impairment of the main mitochondrial function 
of producing adequate ATP (decrease in the ATP/ADP ratio) to satisfy the cell energy 
demand (15, 16, 27). Under these conditions, the brain activates a gene neuroprotection 
program, a sort of hibernating strategy, based on the rationalization of energy production and 
consumption (40). The aim is to reduce the risk of increasing reactive oxygen and nitrogen 
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species, produced/mediated by malfunctioning mitochondria and capable of irreversibly 
damaging biochemically essential molecules (41, 42). Therefore, during the initial 24-36 h 
post injury, relatively modest changes in metabolites and activation of a proper gene strategy 
avoid relevant changes in the glycolytic gene expressions and enzymatic activities. In 
coincidence with the mitochondrial function normalization (recovery of ATP/ADP ratio), 
occurring between 48 and 120 h, glycolysis has to support an increased demand of substrates 
for TCA cycle, ETC and oxidative phosphorylation aimed to restore ATP homeostasis (Fig. 
5). We found that during this period of time (48-120 h post mTBI) gene expressions and 
activities of the four kinases of glycolysis increased 3 to 5 times, clearly leading to an 
increased rate of glucose utilization through glycolysis. The concomitant restoration of 
mitochondrial functions ensured an overall higher glucose consumption coupled to oxygen 
consumption, required to restore ATP to pre impact levels. Therefore, increase of gene 
expressions and activities of glycolytic enzymes occurring in mTBI are related to the 
recovery phase of energy metabolism. This should not be considered as hyperglycolysis but 
as “hyper glucose oxidative metabolism” aimed to support the increased energy demand 
needed for the simultaneous energy replenishment and ongoing cell repair processes (43). The 
lack of increase in whole brain lactate, and of LDH expression and activity, observed in our 
experiments, corroborates this hypothesis, suggesting that mTBI triggers signalling 
mechanisms not involving lactate and acting as positive regulators of the expression of 
glycolytic genes in the metabolic recovery phase post injury. 
Changes in the four kinases following sTBI (Figures 1 and 2) showed bell-shaped curves 
peaking at 24 (gene expressions) or 48 h (enzymatic activities). Early post sTBI (6 h), 
cerebral tissue underwent a sudden 35% ATP decrease and a dramatic 55% reduction of the 
ATP/ADP ratio, accompanied by a 260% rise in lactate, indicating an immediate glucose 
dysmetabolism caused by mitochondrial impairment (Fig. 5). The increase in lactate and ATP 
catabolites (AMP, oxypurines, nucleosides)
 
(13, 44, 45), signalling a marked post injury 
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energy imbalance, mirrored the gene expression increase of HK1, PFKL, PGK1, PK, LDHA 
and LDHB, followed by an increase of the corresponding enzyme activities. This type of 
adaptive response can be interpreted as an attempt to speed up the glycolytic rate, as this 
remains the main pathway to supply ATP during severe mitochondrial malfunctioning. 
Notwithstanding, this metabolic and gene driven hyperglycolysis failed to affect positively 
the cerebral energy state because of the minimal energetic yield of glycolysis (no increase in 
ATP at any time post sTBI). Steady high values of whole brain lactate indicate that the 
combined metabolic and gene stimulation of glycolysis produced an increased rate of 
glycolytically consumed glucose. This occurred during severe mitochondrial malfunctioning 
(very low levels of the ATP/ADP ratio), i.e. when pyruvate produced by glycolysis cannot be 
further metabolized by TCA and is reduced to lactate by increased LDH (LDHA and LDB 
overexpressions). Therefore, these results provide a persuasive explanation that the lactate 
increase, reported in several studies (10, 20, 46-49), is caused by the “true” sTBI-induced 
hyperglicolysis. 
The expressions and activities of the PPP genes and enzymes seem to indicate a close 
relationship with GSH and NADP(H) metabolism, again highlighting profound differences 
between mTBI and sTBI. Whilst G-6PDH and 6-PGDH did not change in mTBI animals, 
increase in gene expression and activity of both dehydrogenases occurred 24-48 h after sTBI. 
However, even in sTBI, neither TKT nor TALDO1 were overexpressed (Table 2), thus 
suggesting that the goal was not to promote a general PPP increase, but rather to activate 
selectively its NADPH-generating reactions. The alterations of GSH, NADPH, NADP
+
, and 
NADPH/NADP
+
 ratio indicate the occurrence of a sustained oxidative/nitrosative stress (50, 
51), causing a transient GSH depletion after an mTBI and a drastic, progressive decrease after 
an sTBI. This confirms the hypothesis that partial PPP activation in severely injured animals 
is connected to GSH homeostasis (25, 46). In sTBI, the increase of the two NADPH-
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producing reactions limited the decrease in the NADPH/NADP
+
 ratio despite a drastic 
depletion of this pyridine nucleotide pool (Fig. 6).  
Summarizing, it appears that the post injured brain, under the pressure of energy imbalance, 
adopts a selected modulation of the genes controlling the expressions of glycolytic and PPP 
pathways, which depends on injury severity. Considering the time course of lactate, energy 
metabolites and mitochondrial phosphorylating capacity, it appears that the resulting increase 
in the glycolytic flux in mTBI is concomitant with the mitochondrial function recovery, i.e. 
glucose consumption is coupled and coincident with glucose oxidation. Additionally, minimal 
or no modifications of the PPP pathway indicate no metabolic switch of glucose metabolism 
aimed to bypass glycolysis. When considering sTBI, it is evident that the net increase in the 
glucose flux through glycolysis (increase in lactate) takes place while mitochondrial 
metabolism is profoundly depressed, i.e. glucose consumption is not coupled and coincident 
with glucose oxidation. The glycolytic gene overexpression, particularly of the four kinases, 
occurred relatively early after injury and might be mediated by metabolite changes 
consequent to the sudden and drastic deterioration in the energy state and mitochondrial 
phosphorylating capacity. Together with the marked lactate increase, these metabolic changes 
most likely acted as signals for specific gene targets (glycolytic genes). Therefore, it appears 
that sTBI produces a “true” hyperglycolytic state aimed to counteract the progressive ATP 
decrease in presence of persistent mitochondrial dysfunction. As even after an sTBI we did 
not observe an overall PPP activation, but a selective activation of its NADPH-generating 
reactions, we can conclude that this is rather linked to maintaining GSH homeostasis (25, 46) 
as opposed to an actual metabolic switch in glucose metabolism (21, 39). 
In conclusion, in this experimental model, a genuine glucose metabolism dysregulation 
occurs only after sTBI, involving deep metabolic alterations acting at the gene level and 
leading to hyperglycolysis during persistent mitochondrial malfunctioning. Conversely, after 
an mTBI positive modulations in the glycolytic gene expressions also occurs, but these are 
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coincident with mitochondrial functional recovery and do not constitute “true” 
hyperglycolysis. The differential biochemical and molecular strategies and their time courses 
adopted by a mildly or a severely injured brain to regulate glucose metabolism have to be 
considered when developing new pharmacological approaches targeting glucose 
dysmetabolism after TBI. Furthermore, it would be highly advisable, either in experimental or 
clinical studies, to specify clearly what severity of injury the results refer to. It is more and 
more evident that the word TBI is merely descriptive of a physical insult. Whether this insult 
does or does not evolve into a multifaceted pathology, characterized by complex mechanisms 
of cerebral cell dysregulation, is strictly dependent on the severity of injury. 
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7. FIGURE LEGENDS 
 
Figure 1. Time course changes of HK1 (Panel A) and PFKL (Panel C) gene expressions, and 
enzymatic activities of HK (Panel B) and PFK (Panel D), in rats receiving mTBI or sTBI. 
Controls are represented by a group of sham operated rats (n = 9). Values at each time point 
are the mean of 6 animals (3 left + 3 right hemispheres). Standard deviations are represented 
by vertical bars. Gene expressions were calculated relatively to -2-microglobulin (B2M). 
One enzymatic unit, relative to protein, corresponds to 1 mol of substrate/min/mg protein 
transformed by the enzyme. 
*significantly different from controls, p < 0.05 
**significantly different from corresponding time of mTBI rats, p < 0.05. 
 
 
 
Figure 2. Time course changes of PGK1 (Panel A) and PKM (Panel C) gene expressions, and 
enzymatic activities of PGK (Panel B) and PK (Panel D), in rats receiving mTBI or sTBI. 
Controls are represented by a group of sham operated rats (n = 9). Values at each time point 
are the mean of 6 animals (3 left + 3 right hemispheres). Standard deviations are represented 
by vertical bars. Gene expressions were  calculated relatively to -2-microglobulin (B2M). 
One enzymatic unit, relative to protein, corresponds to 1 mol of substrate/min/mg protein 
transformed by the enzyme. 
*significantly different from controls, p < 0.05 
**significantly different from corresponding time of mTBI rats, p < 0.05 
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Figure 3. Time course changes of LDHA (Panel A) and LDHB (Panel B) gene expressions, 
and enzymatic activity of total LDH (Panel C), in rats receiving mTBI or sTBI. Controls are 
represented by a group of sham operated rats (n = 9). Values at each time point are the mean 
of 6 animals (3 left + 3 right hemispheres). Standard deviations are represented by vertical 
bars. Gene expressions were calculated relatively to -2-microglobulin (B2M). One 
enzymatic unit, relative to protein, corresponds to 1 mol of substrate/min/mg protein 
transformed by the enzyme. 
*significantly different from controls, p < 0.05 
**significantly different from corresponding time of mTBI rats, p < 0.05 
 
 
 
Figure 4. Time course changes of enzymatic activity of G-6-PDH (Panel A), of 6-PGDH 
gene expression (Panel B), and enzymatic activity of 6-PGDH (Panel C), in rats receiving 
mTBI or sTBI. Controls are represented by a group of sham operated rats (n = 9). Values at 
each time point are the mean of 6 animals (3 left + 3 right hemispheres). Standard deviations 
are represented by vertical bars. Gene expression was calculated relatively to -2-
microglobulin (B2M). One enzymatic unit, relative to protein, corresponds to 1 mol of 
substrate/min/mg protein transformed by the enzyme. 
*significantly different from controls, p < 0.05 
**significantly different from corresponding time of mTBI rats, p < 0.05. 
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Figure 5. Time course changes of cerebral concentrations of ATP (Panel A), ADP (Panel B), 
and of the ATP/ADP ratio (Panel C), in rats receiving mTBI or sTBI. Controls are 
represented by a group of sham operated rats (n = 9). Values of the parameters at each time 
point are the mean of 6 animals (3 left + 3 right hemispheres). Standard deviations are 
represented by vertical bars.  
* significantly different from controls, p < 0.05 
**significantly different from corresponding time of mTBI rats, p < 0.05 
 
 
 
Figure 6. Time course changes of cerebral concentrations of GSH (Panel A), NADP
+
 (Panel 
B), NADPH (Panel C) and of the NADPH/NADP
+
 ratio (Panel D), in rats receiving mTBI or 
sTBI. Controls are represented by a group of sham operated rats (n = 9). Values of the 
parameters at each time point are the mean of 6 animals (3 left + 3 right hemispheres). 
Standard deviations are represented by vertical bars.  
* significantly different from controls, p < 0.05  
** significantly different from the corresponding time in mTBI rats, p < 0.05. 
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Table 1. Sequences of primers used to evaluate the expressions of the gene regulating the 
synthesis of the main glycolytic and pentose phosphate pathway enzymes. 
 
 
Gene symbol Gene sequence Forward Reverse 
 
HK1 
 
NM_012734.1 
 
GCTCAGAAAAGGGGGATTTC 
 
GATGTTCTCTGGGGTGTCGT 
 
PFKL 
 
NM_013190.4 
 
CAACTGGCTCAGTGTCTCCA 
 
GACACACAGGTTGGTGATGC 
 
ALDOC 
 
NM_012497.1 
 
GCCTCTAGCTGGGACTGATG 
 
GCGATCACTGATTTTCAGCA 
 
GAPDH 
 
NM_017008.4 
 
TGCCACTCAGAAGACTGTGG 
 
TTCAGCTCTGGGATGACCTT 
 
PGK1 
 
NM_053291.3 
 
ACAACATGGAGATTGGCACA 
 
GTAGCTTGGCCAGTCTTTGC 
 
ENO2 
 
NM_139325.3 
 
GTGGACCACATCAACAGCAC 
 
TCTCAGTCCCATCCAACTCC 
 
PKM 
 
NM_053297.2 
 
TTTCCAATCCTGCATTCCTC 
 
CCTATCCATTAGGCCAGCAA 
 
LDHA 
 
NM_017025.1 
 
TGTGACTGCAAACTCCAAGC 
 
GAAGCCGCTGATCTTCCAAG 
 
LDHB 
 
NM_012595.1 
 
ACTCCGTGACAGCCAATTCT 
 
CGAAACCGAGCAGAATCCAG 
 
6PGDH 
 
NM_001305435.1 
 
ACTCTTCACTCCTCTGGTGC 
 
ACGTGAACATCCAAGTGTGC 
 
TKT 
 
NM_022592.1 
 
TGTCACCAAGGGCTAGGAAG 
 
CTTTCCACTCGGTACACCCT 
 
TALDO1 
 
NM_031811.3 
 
TCACCATCTCACCCAAGCTT 
 
AGAGCTTCTCCACAGCCATT 
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Table 2. Changes in the expression of the genes encoding for the glycolytic enzymes aldolase 
(ALDOC), glyceraldehydes-3-phosphate dehydrogenase (GAPDH) and enolase (ENO2), as 
well as for the PPP enzymes transketolase (TKT) and transaldolase (TALDO1), following 
mTBI or sTBI. 
 
 
 ALDOC/B2M GAPDH/B2M ENO2/B2M TKT/B2M TALDO1/B2M 
 
Control 
 
1.00  0.07 
 
1.02  0.28 
 
1.03  0.29 
 
1.02  0.29 
 
1.07  0.11 
 
mTBI 6 h 
 
1.07  0.06 
 
0.59  0.12 
 
1.22  0.23 
 
0.77  0.23 
 
0.89  0.18 
 
mTBI 24 h 
 
1.02  0.23 
 
1.21  0.21 
 
1.36  0.27 a 
 
0.85  0.27 
 
1.14  0.20 
 
mTBI 48 h 
 
1.53  0.22a 
 
1.29  0.16 
 
1.74  0.40 a 
 
1.05  0.40 
 
0.85  0.21 
 
mTBI 120 h 
 
1.51  0.31a 
 
1.94  0.19 a 
 
2.34  0.37 a 
 
0.86  0.37 
 
0.96  0.27 
 
sTBI 6 h 
 
1.01 0.24 
 
0.57  0.14 
 
0.72  0.09 
 
0.87  0.19 
 
0.67  0.09a 
 
sTBI 24 h 
 
1.31  0.34 
 
1.50  0.35 a 
 
1.03  0.11 
 
0.89  0.21 
 
0.69  0.12a 
 
sTBI 48 h 
 
1.58  0.18a 
 
1.01  0.19 
 
0.88  0.25 
 
0.78  0.25 
 
0.78  0.25 
 
sTBI 120 h 
 
1.16  0.06 
 
0.74  0.25 
 
0.89  0.21 
 
0.69  0.21a 
 
0.69  0.21a 
 
Values are the means  standard deviations of six different animals. Gene expressions are 
reported as the ratios with the housekeeping gene B2M. 
a
significantly different from controls, p < 0.05. 
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Fig. 1 
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Fig. 2 
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Fig. 3 
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Fig. 4 
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Fig. 5 
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Fig. 6 
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Highilights  
 
 
 
- Metabolic, enzymatic and gene changes are involved in glucose dysmetabolism after 
TBI  
- Activation of glycolysis in mild TBI occurs on recovery of mitochondrial functions 
- Activation of glycolysis in severe TBI occurs during mitochondrial malfunctioning 
- Pentosephosphate pathway changes in severe TBI are limited to NADPH supply  
- Metabolic and gene mechanisms of glucose dysregulation depend on TBI severity 
